HELP——海德堡肺癌患者决策辅助工具:一项随机对照临床试验
HELP研究是一项随机、对照、开放、单中心、两组平行的临床试验,评估HELP决策辅助手册联合决策辅导对晚期肺癌患者决策冲突的影响,主要终点为决策辅导后决策冲突量表所操作化的个人态度清晰度,对照组接受常规诊疗。
要点
- HELP研究采用随机、对照、开放、单中心、两组平行设计,按基线偏好决策特征分层区组随机,1:1分配。
- 干预为使用HELP决策辅助手册并伴随一次决策辅导,对照为常规诊疗即无预先辅导的医患对话。
- 主要终点为决策辅导后经决策冲突量表(DCS)操作化的个人态度清晰度。
核心结论
- 研究旨在评估HELP决策辅助工具的有效性。
研究设计与样本
- 随机、对照、开放、单中心、两组平行的临床试验。
- 按基线偏好决策特征进行分层区组随机,1:1分配。
- 干预组使用HELP决策辅助手册并伴随决策辅导,对照组接受常规诊疗即无预先辅导和偏好目标讨论的医患对话。
主要发现
- 主要终点为决策辅导后经决策冲突量表(DCS)操作化的个人态度清晰度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shared decision-making (SDM), which increases the patient's well-being, adherence, and success of treatment, is becoming increasingly important in medicine and especially in oncology. To empower patients to participate more actively in consultations with their physicians decision aids have been developed. In non-curative settings, such as the treatment of advanced lung cancer, decisions differ substantially from the curative setting, as uncertain gains in terms of survival outcomes and quality of life have to be weighed against the severe side effects of treatment regimens. There is still a lack of tools developed and implemented for such specific settings in cancer therapy that support shared decision-making. The aim of our study is to evaluate the effectiveness of the HELP decision aid. METHODS: The HELP-study is designed as a randomized, controlled, open monocenter trial with two parallel groups. The intervention consists of the use of the HELP decision aid brochure, accompanied by a decision coaching session. The primary endpoint is clarity of personal attitude as operationalized by the Decisional Conflict Scale (DCS) after the decision coaching. Randomization will be performed as stratified block randomization according to the characteristic of preferred decision-making at baseline with a 1:1 allocation. The participants in the control group get usual care, i.e., the doctor-patient conversation takes place without preliminary coaching and deliberation about their preferences and goals. DISCUSSION: Developing decision aids (DA) for (lung) cancer patients with limited prognosis should empower patients to address these aspects and include information about "Best Supportive Care" as a treatment option. Using and implementing the decision aid HELP can not only give patients the possibility to include their personal wishes and values in the decision-making process, but also raise the awareness of shared decision-making itself among these patients and their physicians. TRIAL REGISTRATION: German Clinical Trial Register DRKS00028023. Registered on 8 February 2022.
引用
- Deis N, Unsöld L, Siegle A, et al. HELP - Heidelberg decision aid for lung cancer patients: a randomized controlled clinical trial. Trials. 2023. PMID: 37231417. doi:10.1186/s13063-023-07365-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。